Daria D. Nikolaeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daria D. Nikolaeva has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr A. Arzamasov
Sanford Burnham Prebys Medical Discovery Institute
1 shared publication - Andrei L. Osterman
Sanford Burnham Prebys Medical Discovery Institute
1 shared publication - Anissa M. Armet
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada
1 shared publication - Arya Sharma
Department of Medicine University of Alberta Edmonton Alberta Canada
1 shared publication - Benjamin Seethaler
Institute of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany
1 shared publication - Bernard Berger
Nestlé Institute of Health Sciences, Société des Produits Nestlé S.A., 1000 Lausanne 26, Switzerland
1 shared publication
Latest Publications
- Open Access
Mechanistic insights into microbiome-dependent and personalized responses to dietary fibre in a randomized controlled trial
Dietary fiber supplementation can reduce cardiometabolic risk, but its effective use is limited by incomplete understanding of fibre-microbiome interactions and highly individualized responses. We tested acacia gum (AG; fermentable fibre), resistant starch type 4 (RS4; fermentable fibre), and microcrystalline cellulose (MCC; non-fermentable control fibre) in a six-week randomized trial in adults with excess body weight. Multi-omics profiling revealed distinct, structure-specific microbiota and short-chain fatty acid shifts with AG and RS4, which were not directly linked to physiological outcomes. Improvements in inflammation, gut barrier function, and satiety occurred across all arms, indicating fermentation-independent effects. AG reduced plasma ghrelin, linked to microbial carbohydrate-active enzyme genes targeting its structures. Machine-learning models predicted individualized, fiber-specific effects on blood pressure (AG) and C-reactive protein (RS4) from microbial pathways and fecal bile acids. These findings delineate fermentation-dependent and independent mechanisms of fibre action and provide a mechanistic basis for personalized fibre supplementation. Trial registration: ClinicalTrials.gov NCT02322112
Open AccessMechanistic insights into microbiome-dependent and personalized responses to dietary fibre in a randomized controlled trial
Dietary fiber supplementation can reduce cardiometabolic risk, but its effective use is limited by incomplete understanding of fibre-microbiome interactions and highly individualized responses. We tested acacia gum (AG; fermentable fibre), resistant starch type 4 (RS4; fermentable fibre), and microcrystalline cellulose (MCC; non-fermentable control fibre) in a six-week randomized trial in adults with excess body weight. Multi-omics profiling revealed distinct, structure-specific microbiota and short-chain fatty acid shifts with AG and RS4, which were not directly linked to physiological outcomes. Improvements in inflammation, gut barrier function, and satiety occurred across all arms, indicating fermentation-independent effects. AG reduced plasma ghrelin, linked to microbial carbohydrate-active enzyme genes targeting its structures. Machine-learning models predicted individualized, fiber-specific effects on blood pressure (AG) and C-reactive protein (RS4) from microbial pathways and fecal bile acids. These findings delineate fermentation-dependent and independent mechanisms of fibre action and provide a mechanistic basis for personalized fibre supplementation. Trial registration: ClinicalTrials.gov NCT02322112